INTRODUCTION AND OBJECTIVES:
To examine postoperative complications in a contemporary series of patients after radical cystectomy (RC) using the comprehensive complication index (CoCI), a new extension of the Clavien-Dindo-Classification (CDC), that integrates not only the most severe but all events with their respective severity.
METHODS: Using the CoCI, we assessed the 90-day postoperative clinical course of 804 bladder cancer patients who underwent open RC and urinary diversion (ileal conduit n ¼ 510, ileal neobladder n ¼ 294) between June 2003 and December 2015 at a single institution. All Martin criteria for standardized reporting of complications were met. The CoCI is calculated as the sum of all CDC events that are weighted for their severity. The final formula yields a continuous scale to rank the severity of any combination of complications from 0 to 100 in a single patient. Cut-off of the CoCI was set at 26.2%, the equivalent of a single CDC IIIa complication, to assess major complications. Uni-and multivariable analyses for prediction of complications were carried out; covariables included body mass index, Charlson Comorbidity Index (CCI), age, sex, American Society of Anesthesiologists Score (ASA), neoadjuvant chemotherapy, prior abdominal or pelvic surgery, clinically localized tumor and urinary diversion type.
RESULTS: The 90-day rates for overall (CDC I-V) and highgrade complications (CDC III-V), as well as mortality (CDC V), were 58.8, 21.8 and 3.7%, respectively. The median CoCI was 20.9 (IQR 0-29.6) with a CoCI26.2 in 29.2% of the study population. Patients that received an ileal neobladder had a significantly lower CoCI, 8.7% (IQR 0-22.6), compared to those that received ileal conduit, 20.9% (IQR 0-33.7, P¼0.013). Independent risk factors for overall complications were BMI30 (OR 1.75), female gender (OR 1.66) and ASA3 (OR 1.47). Risk factors for a CoCI26.2 were BMI30 (OR 1.52), CCI3 (OR 1.63) and ASA3 (OR 1.72, all P<0.05).
CONCLUSIONS: RC is associated with significant morbidity; nevertheless, the majority of complications are minor. CCI, ASA and BMI might help to identify patients at risk for major complications after radical cystectomy. The comprehensive complication index gives detailed and acurate information on the individual burden of complications. Patients with a history of prior abdominal/pelvic radiation (RT) are thought to be at increased risk for post-operative complications and adverse pathology with RC. Hence, RC may be underutilized in this population. Our objective was to compare post-operative complication rates and pathologic outcomes after RC in patients with prior abdominal/pelvic RT versus those without a RT history.
Source of
METHODS: An IRB approved retrospective cohort study for patients who underwent RC for urothelial carcinoma (UC) at our institution between 2008-2016 was performed. The cohorts included: any prior abdominal/pelvic RT and no prior RT. Outcomes assessed between cohorts included diversion type, final pathology, length of surgery (ORT) and hospital stay (LOS), blood loss (EBL) and post-operative recovery and complications. RESULTS: We identified 519 patients who underwent RC for UC during the time period studied. Of these, 56 (11%) patients had a history of abdominal/pelvic RT. All previously radiated patients had received RT for pelvic malignancy, most commonly for prostate cancer (60%). When stratified by prior RT, there were no significant differences in EBL, intra-operative transfusion, and time to bowel function. The overall complication rate in RT patients versus those without prior RT was 48% and 52% respectively (p ¼ 0.74). While there was no statistical difference in fascial dehiscence rate (p ¼ 0.075), there did appear to be a clinically significant difference in rate (25% in those with RT versus 9% in those without RT. Comparisons of pathologic features demonstrated no significant difference between the groups for histology, metastases, margin status, cancer specific and overall survival. However, a significant difference in T-classification was observed, with RT patients being more likely to have pT4 disease (p¼0.04).
CONCLUSIONS: Although RC remains a surgical procedure with high complication rates, patients with a history of prior abdominal/ pelvic RT do not appear to have a higher complication rate and should not be excluded from RC on the basis of prior RT alone. Despite the fact that radiated patients are at greater risk for higher pathologic stage, there were no detectable differences in cancer specific and overall survival. Additional prospective studies are needed to better evaluate this cohort of patients to inform treatment decisions.
Source of Funding: None

MP54-03 BENEFITS AND COMPLICATIONS DURING INPATIENT FOLLOW-UP TREATMENT AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER
Gerald Schulz*, Tobias Grimm, Alexander Buchner, Friedrich Jokisch, Markus Grabbert, Birte-Swantje Schneevoigt, Alexander Kretschmer, Christian Stief, Alexander Karl, 81377 Munich, Germany INTRODUCTION AND OBJECTIVES: A three-week inpatient follow-up treatment (FT) in government-approved rehabilitation clinics is offered after radical cystectomy (RC) for bladder cancer (BC) for all patients in Germany. We investigated both the physical condition and expectations of the patients at the beginning of the FT as well as complications during the 3-week period and results thereafter. METHODS: 81 patients from different urological departments who underwent RC for BC and an orthotopic neobladder reconstruction were included. Time from hospital discharge until beginning of FT, BMI, initial blood count, Karnovsky scale, antibiotics, antithrombotics and use of incontinence pads were assessed. Furthermore patients were asked for main complaints as well as expectations towards the three-week FT. Complications like metabolic acidosis and urinary tract infections during FT as well as medication, incontinence pad use and patients' complaints after FT were monitored. RESULTS: Median time between RC and discharge from the primary hospital to FT was 35 days (interquartile range [IQR] 25-41 days) and 13 days ([IQR] 4-16 days) respectively. The medical condition at the beginning of FT was good: mean Karnovsky 72% ([IQR] 70-88%), mean BMI 23.1 ([IQR] 20.9-27.7), mean hemoglobin, creatinine and leukocytes in the normal range. The five most common complaints mentioned are general weakness (79%), incontinence (77%), pain (31%), fatigue (30%), and mental distress (43%). The three most important expectations towards FT were improvement of the general physical capacity (86%), followed by improvement of incontinence (81%) and reduction of mental distress (31%). During FT 25.9% of patients had a urinary tract infection requiring antibiotics and 8.6% had a symptomatic metabolic acidosis. Only 18.1% were under antithrombotic medication at the beginning of FT. Antibiotic use decreased from 19.8% to 17.3%. Incontinence pad use increased from 2.14 to 2.55 pads per day on average. At the end of FT, patients indicated improvement of incontinence, physical capacity and mental distress in 60.5%, 74.1% and 30.86%.
CONCLUSIONS: Compared to the pre-and perioperative management of BC, there is a scarcity of studies investigating FT of BC. A multitude of significantly different FT models have been implemented in different countries. Both from the economic as well as medical point of view high-quality FT must be strived for. Our study gives insights into the current state of FT in Germany and shows both benefits as well as unsolved challenges.
Source of Funding: none
MP54-04 HOSPITALIZATION AND READMISSION COSTS AFTER RADICAL CYSTECTOMY IN A NATIONALLY REPRESENTATIVE SAMPLE: NEOBLADDER VS. ILEAL CONDUIT
Gregory Joice*, Meera Chappidi, Hiten Patel, Max Kates, Nikolai Sopko, CJ Stimson, Phillip Pierorazio, Trinity Bivalacqua, Baltimore, MD INTRODUCTION AND OBJECTIVES: Current studies have failed to show clear long-term differences in oncologic outcomes or quality of life between Ileal Conduit (IC) and neobladder after Radical Cystectomy (RC). However, few studies have assessed cost differences between diversion types. We analyzed the differences in hospital costs during initial hospitalization and readmissions between neobladder and IC in a nationally representative sample.
METHODS: The 2013 Nationwide Readmissions Database (NRD) was queried for patients with bladder cancer undergoing RC. Sociodemographic characteristics, Length of Stay (LOS), hospital costs, and causes of readmission were compared between neobladder and IC. Univariable and multivariable logistic regression models were utilized to assess the impact of urinary diversion type on LOS, readmission rates, and hospitals costs. Costs were modeled using the gamma distribution to account for skewness of data.
RESULTS: Among 4,283 patients included in the analysis, 325 (7.5%) underwent neobladder reconstruction with the remainder undergoing IC. Patient's with a neobladder were younger (mean age 62 years vs. 69, p <0.001), had a lower Charlson Comorbidity Index (CCI) (CCI of 0 e 69%, vs. 47%, p<0.001), private insurance (44% vs. 24%, p <0.001), higher median household income (Top quartile e 35% vs. 24%, p¼ 0.02), and were more likely to be treated at high volume metropolitan teaching centers (High volume e 54% vs. 33%, p<0.001). Between the two groups, there was no difference in initial hospitalization LOS, readmission rate, readmission LOS, or 90-day mortality. Neobladders were more likely to be readmitted for hydronephrosis (2.7% vs. 0.3%, p < 0.001) and UTI/Pyelonephritis (18.9% vs. 11.4%, p ¼ 0.066) though the latter did not reach statistical significance. Neobladder mean costs were higher for the initial hospitalization and at 30-day and 90 days. At 90-days, neobladders cost on average $14,000 more per patient than IC. On multivariable analysis, neobladder was an independent predictor of increased cost during readmission (OR 3.41, p < 0.001).
CONCLUSIONS: Neobladder diversion after RC is more costly compared to IC both during initial admission and at 90-days despite similar LOS and readmission rates. The increased cost of care may be secondary to increased treatment for obstructive and infectious complications. In an era of changing reimbursements, cost of diversion may also need to be considered when selecting diversion type. is widely used to predict post-op morbidity and mortality in procedure specific models. No validation has been done of its accuracy for urologic surgeries. The goal of this study is to evaluate the ability of NSQIP surgical risk calculator to predict the 30-day complications, readmission, reoperation, and mortality after radical cystectomy for bladder cancer.
Source of Funding: None
METHODS: Medical records of all bladder cancer patients who underwent radical cystectomy between 2008 and 2015 were retrospectively reviewed. The data were collected according the NSQIP's definitions. NSQIP calculator was used to predict the probability of complications for these patients. NSQIPRC predicted complication rates were compared to the observed complication rates in our institute using c-statistics, the area under the receiver operating characteristic (ROC) curve, and Brier's score to measure the calibration and discrimination.
RESULTS: We identified 439 who underwent radical cystectomy for bladder cancer. One main weakness of the NSQIPRC is its inability of predicting gastroenterological and urinary tract complications, these complications occurred in 136 (30%) and 49 (11%) patients respectively. Even after eliminating these complications from our analysis, the mean NSQIPRC predicted rates were lower than the observed rates of serious complications ( 25% vs 34%), any complications (28% vs 35%), readmission (19% vs 27%), and reoperation (4% vs 6.5%) respectively. The NSQIPRC did not perform well with area under the ROC curve was (0.563) for serious complication, (0.551) for any complication, (0.515) for readmission, and (0.587) for reoperation. However, the calculator had acceptable prediction of mortality (c-statistic 0.729, Brier's score 0.02), and poor in predicting pneumonia (c-statistic 0.629, Brier's score 0.022) and deep venous thrombosis (c-statistic 0.625, Brier's score 0.032).
CONCLUSIONS: NSQIP risk factor calculator underestimates the probability of post-op morbidity. It underperforms in predicting the rates of serious complications, any complication, readmission, and reoperation. Nonetheless, it is reasonable in predicting mortality after surgery. Major improvements in data processing and calculator design are needed.
MP54-06
IMPACT OF SURGICAL VOLUME ON SURVIVAL FOLLOWING RARC IN A LARGE, NATIONAL COHORT Patrick Lewicki*, David Golombos, New York, NY; Padraic O'Malley, Halifax, Canada; Clara Oromendia, Abimbola Ayangbesan, LaMont Barlow, Douglas Scherr, New York, NY INTRODUCTION AND OBJECTIVES: Robotic-assisted radical cystectomy (RARC) has become increasingly utilized in treatment of muscle-invasive bladder cancer, yet the limited data to support its oncologic efficacy comes largely from high volume centers. RARC represents a technically demanding procedure, and results may not be reproducible across multiple surgeons and institutions. We aim to assess the effect of center volume on survival outcomes in patients undergoing RARC.
METHODS: Using the National Cancer Data Base (NCDB) we identified patients undergoing RARC from 2010-2012. Center volume was defined by the number of RARC performed over the study period. Low volume centers were defined by <10 RARC, representing the lowest tertile. Univariable and multivariable regression modeling was Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e723
